Rerefined model

PDB 4B05|dpdb_7cqtc4f6

Rerefined model

Preclinical characterization of AZD3839, a novel clinical candidate BACE1 inhibitor for the treatment of Alzheimer Disease

Program
PHENIX 2.0_5824
Model type
Multiconformer
Purpose
Refinement
Atoms
3,416
Residues
371
Protein chains
1
Alternate-location fraction
0%
Ligands
32D, ACT, NA

Evaluations

R-work
0.168
R-free
0.216
Clashscore
6.2

Macromolecules

The same in every model of this entry.

Entity 1
MoleculeChainsLengthOrganismUniProtDetails
BETA-SECRETASE 1411
  • ConstructRESIDUES 43-453
  • MutationsYES

Data

L0 Raw
L1 Processed
L2 Models
L3 Evaluations